ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,881,546 | +24.9% | 973,843 | +40.2% | 0.01% | +33.3% |
| Q2 2023 | $19,925,689 | +70.9% | 694,854 | +42.8% | 0.01% | +50.0% |
| Q1 2023 | $11,659,986 | +226880.5% | 486,621 | +60.7% | 0.00% | +100.0% |
| Q4 2022 | $5,137 | -99.8% | 302,861 | +111.6% | 0.00% | +100.0% |
| Q3 2022 | $2,120,000 | -9.8% | 143,118 | -4.2% | 0.00% | 0.0% |
| Q2 2022 | $2,351,000 | -59.9% | 149,392 | -31.3% | 0.00% | -50.0% |
| Q1 2022 | $5,866,000 | +111.5% | 217,572 | +190.3% | 0.00% | +100.0% |
| Q4 2021 | $2,773,000 | – | 74,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
| Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
| ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
| MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
| Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
| Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
| Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
| New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |